Search
for
Sort by
Research 30 of 502
- Monovalent antibody-conjugated lipid-polymer nanohybrids for active targeting to desmoglein 3 of keratinocytes to attenuate psoriasiform inflammation
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- Caractérisation des Réactions Paradoxales Psoriasiformes Alopéciantes Induites par les Anti-TNFα chez des Patients Atteints de Maladies Inflammatoires Chroniques de l’Intestin
- 1113 Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation
- 713 Fisetin promotes differentiation, inhibits proliferative and inflammatory responses in cultured human cells and alleviates psoriasiform dermatitis in mice
- ZNF750 safeguards upper hair follicle homeostasis to prevent inflammatory skin disease
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- 176 Myeloid cell-specific deletion of mTOR suppresses psoriasis-like skin inflammation in C57BL/6 mice
- 305 Overlaps between inflammatory dermatoses and ichthyoses: need for novel therapeutic approaches
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- 1114 Study of long-term (15-day) imiquimod treatment and drug intervention in localized psoriasiform dermatitis model
- Anti-TNF-Alpha Induced Psoriasiform Eruptions with Severe Scalp Involvement and Alopecia: Report of Five Cases and Review of the Literature
- A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice.
- Cutaneous manifestations of methylmalonic and propionic acidaemia: a description based on 38 cases
- Alopecia secondary to anti-tumor necrosis factor-alpha therapy
- Psoriatic Alopecia/Alopecia Areata–Like Reactions Secondary to Anti–Tumor Necrosis Factor-α Therapy: A Novel Cause of Noncicatricial Alopecia
- Tumor necrosis factor-alpha inhibitor associated psoriasiform alopecia (drug-induced psoriasiform alopecia)
- A case of dupilumab-induced psoriatic alopecia
- Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors: A Clinical Review of Reaction Patterns
- Adalimumab-related alopecia in a patient affected by psoriasis
- Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support
- Disorders of hair growth and the pilosebaceous unit: Facts and controversies
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Drug-induced skin reactions: a pathologist viewpoint
- Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis
- LB1605 3D imaging of cleared ex vivo normal human skin, skin appendages and psoriasiform skin lesion using light-sheet microscopy
- Regulatory T cells in inflammatory skin disease: from mice to humans
- Anti-inflammatory role of 15-lipoxygenase contributes to the maintenance of skin integrity in mice
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation